Abstract 250P
Background
It is widely believed that nutritional and psychological disorders can affect the outcome of cancer treatment and the life quality of patients. However, the importance of nutritional and psychological interventions is still underestimated, and cancer treatment remains the main focus of clinical practice. In order to raise awareness of clinicians, we conducted a survey of nutritional and psychological status of cancer patients.
Methods
From December 2020 to January 2022, 1000 patients with advanced cancer completed the online survey of stardard nutritional and psychological scales.
Results
All the patients had solid tumors, and most(84.1%) of them had trouble in life quality caused by cancer treatment. The survey indicated 74.7% of the patients had at least once nutritional risk. Psychological disorders referred to three terms including insomnia, anxiety and depression. Patients experienced mild, moderate and severe insomnia was respectively 48.2%, 18.5% and 1.5%; mild, moderate and severe anxiety was respectively 57.5%, 25.5% and 3.3%; mild, moderate and severe depression was respectively 20.7%, 9.5% and 2.3%. Surprising 92.7% of the patients had never received any nutritional or psychological intervention.
Conclusions
There is an urgent need to assess the nutritional and psychological status of cancer patients in the early stage of treatment, and implement effective interventions to enable more patients to live longer and better.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
140P - Lenvatinib + everolimus in mRCC that has progressed on immunotherapy: A real-world single center experience
Presenter: CHINNU JOMI
Session: Poster viewing 03
141P - Real-world study of cabozantinib treatment of advanced renal cell carcinoma in Taiwan
Presenter: Yu-Chieh Tsai
Session: Poster viewing 03
143P - Clinical outcomes of systemic therapy for hemodialysis patients with metastatic renal cell carcinoma
Presenter: Shun Iwasa
Session: Poster viewing 03
144P - Association between immune-related adverse events and survival in metastatic renal cell carcinoma treated with nivolumab plus ipilimumab
Presenter: Takanori Hayase
Session: Poster viewing 03
145P - Treatment outcomes and FGFR alterations in unresectable locally advanced or metastatic urothelial cancer in Taiwan
Presenter: Jian-Ri Li
Session: Poster viewing 03
146P - Comparison of the survival outcomes between primary and secondary muscle-invasive bladder cancer: A propensity score-matched Chinese cohort
Presenter: WAICHAN LOK
Session: Poster viewing 03
Resources:
Abstract
147P - Activity of single-agent PD-1/PD-L1 inhibitors in 1st-line (1L) “platinum-ineligible” patients (pts) with metastatic urothelial cancer (mUC) in real-life clinical practice
Presenter: Javier Molina Cerrillo
Session: Poster viewing 03
149P - A need for clear definitions and improved management for BCG-unresponsive tumors in Asia-Pacific
Presenter: Lui Shiong Lee
Session: Poster viewing 03
Resources:
Abstract